MindRank

The MindRank team is composed of experts in the fields of AI-driven drug discovery, medicinal chemistry, and molecular biology. Members come from well-known multinational pharmaceutical companies, leading internet enterprises, and world-renowned universities. The team is committed to improving the efficiency and success rate of new drug research and development to meet unmet clinical needs. Its AI pharmaceutical solutions have been recognized by the authoritative institution Deep Pharma Intelligence as "one of the 11 most important AI drug discovery breakthrough achievements globally from 2018 to 2020," sharing honors with companies like DeepMind and Exscientia. Additionally, in 2020, it stood out among hundreds of EU projects, being selected for the "EU Innovative Medicines Initiative" and receiving tens of millions of euros in funding. The company is led by fellows of the UK’s two national academies, top pharmaceutical enterprises in and outside China, and AI scientists. Team members possess extensive successful experience in drug discovery and have published world-class papers in Nature, Science, and Cell. We focus on the development of drugs targeting innovative and difficult-to-drug targets and have independently developed, as well as collaborated on, multiple pipelines in the field of oncology.